The EU's medicines regulator has said that the Oxford-AstraZeneca vaccine should continue to be used because its benefits far outweigh its risks. (Subscribe: [ Ссылка ])
A final ruling is expected on Thursday, but the European Medicines Agency has been alarmed that at least 12 European nations have suspended the use of the vaccine after a small number of cases, some of them fatal, of blood clots among people who have received the AstraZeneca jab.
The EMA pointed out that it believed this was purely coincidental.
-----------------------
Follow us on Instagram - [ Ссылка ]
![](https://i.ytimg.com/vi/TlyNLSyeCO0/maxresdefault.jpg)